One extra shot around embryo transfer may lift IVF live birth rates

NCT ID NCT02357654

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This trial tests whether a single injection of a GnRH agonist given around the time of embryo transfer can improve the chance of a live birth in women under 40 undergoing IVF, ICSI, or frozen embryo transfer. Participants receive either the GnRH shot or a placebo, and researchers track live birth rates, implantation, clinical pregnancy, and risk of ovarian hyperstimulation syndrome. The goal is to see if this simple hormonal boost helps the uterus support a pregnancy after embryo transfer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GnRH agonist (single injection)
What this could lead to
If it works, this simple additional shot could increase the chance of a live birth after IVF or frozen embryo transfer.
What could go wrong
This is a single-center Phase 4 trial; results may not apply to all IVF patients. The GnRH agonist carries a small risk of ovarian hyperstimulation syndrome (OHSS).

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INFERTILITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Reproductive Associates

    RECRUITING

    Hasbrouck Heights, New Jersey, 07604, United States

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.